Design, synthesis and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part I
…, K Wolff, H Yin, K Bieza, J Caldwell, B Bursulaya…
Index: Jiang, Tao; Kuhen, Kelli L.; Wolff, Karen; Yin, Hong; Bieza, Kimberly; Caldwell, Jeremy; Bursulaya, Badry; Wu, Tom Yao-Hsing; He, Yun Bioorganic and Medicinal Chemistry Letters, 2006 , vol. 16, # 8 p. 2105 - 2108
Full Text: HTML
Citation Number: 133
Abstract
A novel oxindole was discovered as an HIV non-nucleoside reverse transcriptase inhibitor via HTS using a cell-based assay. Systematic structural modifications were carried out to establish its SAR. These modifications led to the identification of oxindoles with low nanomolar potency for inhibiting HIV replication. These novel and potent oxindoles could serve as advanced leads for further optimizations.
Related Articles:
[Fensome, Andrew; Bender, Reinhold; Cohen, Jeffrey; Collins, Mark A; Mackner, Valerie A; Miller, Lori L; Ullrich, John W; Winneker, Richard; Wrobel, Jay; Zhang, Puwen; Zhang, Zhiming; Zhu, Yuan Bioorganic and medicinal chemistry letters, 2002 , vol. 12, # 23 p. 3487 - 3490]
[Fensome, Andrew; Bender, Reinhold; Cohen, Jeffrey; Collins, Mark A; Mackner, Valerie A; Miller, Lori L; Ullrich, John W; Winneker, Richard; Wrobel, Jay; Zhang, Puwen; Zhang, Zhiming; Zhu, Yuan Bioorganic and medicinal chemistry letters, 2002 , vol. 12, # 23 p. 3487 - 3490]
[Li, Bin; Park, Yoonsu; Chang, Sukbok Journal of the American Chemical Society, 2014 , vol. 136, # 3 p. 1125 - 1131]